Why Molnupiravir Fails in Hospitalized Patients

Why Molnupiravir Fails in Hospitalized Patients

ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has radically altered daily life. Effective antiviral therapies to combat COVID-19, especially severe disease, remain scarce. Molnupiravir is an antiviral that has shown...

Full description

Bibliographic Details
Main Authors: Ashley N. Brown, Yinzhi Lang, Jieqiang Zhou, Evelyn J. Franco, Kaley C. Hanrahan, Juergen B. Bulitta, George L. Drusano
Format: Article
Language:English
Published: American Society for Microbiology 2022-12-01
Series:mBio
Subjects:
antivirals
hollow fiber infection model
molnupiravir
SARS-CoV-2
pharmacodynamics
Online Access:https://journals.asm.org/doi/10.1128/mbio.02916-22

Internet

https://journals.asm.org/doi/10.1128/mbio.02916-22

Similar Items